OPA Begins Rule-making for 340B Dispute Resolution and Manufacturer Fines for Overcharges
Drug Companies Begin Denying 340B Pricing on Orphan Drugs to Children's Hospitals
Calif. Counties and Drug Firms Still Sparing Over 340B Records Disclosure
CMS Plans To Withdraw AMP Rules Without a Timetable for a Replacement
CMS Taps Just One Children's Drug for New 17.1 Percent Medicaid Rebate
CMS Proposes Hike in Medicare Part B Drug Payments, Lower Inpatient Reimbursement
New Health Insurance Exchanges Could Expand 340B's Reach
Small Provision in Health Care Reform Law Could Have a Big Effect on Drug Settlements
Access our quarterly print newsletter!
82 New Hospitals Join 340B Program in First Month of Eligibility
PSSC Accepting Applications for 340B Peer Mentoring Competition
Trustees' Report Finds Medicare Part D Drug Benefit Is Costing Less than Expected
 |
September 14, 2010—The Drug Discount Monitor is now producing an enhanced print edition four times a year. It's replaced our old monthly newsletter and gives you a compilation of our best recent online articles. Please contact Tom Mirga at tom.mirga@drugdiscountmonitor.com or 202-552-5853 to let us know if you want to receive the quarterly print edition by mail for a small additional fee.
